{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:17:06Z","timestamp":1791303426434,"version":"4.1.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401072"],"award-info":[{"award-number":["82401072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-026-10052-7","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:11:58Z","timestamp":1779171118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bone as an endocrine regulator of lipid and energy metabolism"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-4091","authenticated-orcid":false,"given":"Hanghang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9642-5391","authenticated-orcid":false,"given":"Junyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4490-8368","authenticated-orcid":false,"given":"Linyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6196-0287","authenticated-orcid":false,"given":"Wangyang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2265-1762","authenticated-orcid":false,"given":"Shibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-1097","authenticated-orcid":false,"given":"En","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-8199","authenticated-orcid":false,"given":"Clifford J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"12","key":"10052_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41574-025-01162-4","volume":"21","author":"B Lecka-Czernik","year":"2025","unstructured":"Lecka-Czernik B, Rosen CJ, Napoli N. The role of bone in whole-body energy metabolism. Nat Rev Endocrinol. 2025;21(12):743\u201356. https:\/\/doi.org\/10.1038\/s41574-025-01162-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10052_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2010.06.003","volume":"48","author":"M Askmyr","year":"2011","unstructured":"Askmyr M, Quach J, Purton LE. Effects of the bone marrow microenvironment on hematopoietic malignancy. Bone. 2011;48(1):115\u201320. https:\/\/doi.org\/10.1016\/j.bone.2010.06.003.","journal-title":"Bone"},{"issue":"1","key":"10052_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-021-00142-4","volume":"9","author":"R Zhou","year":"2021","unstructured":"Zhou R, Guo Q, Xiao Y, et al. Endocrine role of bone in the regulation of energy metabolism. Bone Res. 2021;9(1):25. https:\/\/doi.org\/10.1038\/s41413-021-00142-4.","journal-title":"Bone Res"},{"issue":"2","key":"10052_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00223-016-0210-y","volume":"100","author":"N Bonnet","year":"2017","unstructured":"Bonnet N. Bone-derived factors: a new gateway to regulate glycemia. Calcif Tissue Int. 2017;100(2):174\u201383. https:\/\/doi.org\/10.1007\/s00223-016-0210-y.","journal-title":"Calcif Tissue Int"},{"key":"10052_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00122","volume":"11","author":"C Cipriani","year":"2020","unstructured":"Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne). 2020;11:122. https:\/\/doi.org\/10.3389\/fendo.2020.00122.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10052_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4248\/BR201301005","volume":"1","author":"FJ de Paula","year":"2013","unstructured":"de Paula FJ, Rosen CJ. Bone remodeling and energy metabolism: new perspectives. Bone Res. 2013;1(1):72\u201384. https:\/\/doi.org\/10.4248\/BR201301005.","journal-title":"Bone Res"},{"issue":"11","key":"10052_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","volume":"15","author":"N Dirckx","year":"2019","unstructured":"Dirckx N, Moorer MC, Clemens TL, Riddle RC. The role of osteoblasts in energy homeostasis. Nat Rev Endocrinol. 2019;15(11):651\u201365. https:\/\/doi.org\/10.1038\/s41574-019-0246-y.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10052_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molmet.2014.12.010","volume":"4","author":"NJ Lee","year":"2015","unstructured":"Lee NJ, Nguyen AD, Enriquez RF, et al. NPY signalling in early osteoblasts controls glucose homeostasis. Mol Metab. 2015;4(3):164\u201374. https:\/\/doi.org\/10.1016\/j.molmet.2014.12.010.","journal-title":"Mol Metab"},{"issue":"7","key":"10052_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1177\/0192623317737065","volume":"45","author":"KJ Motyl","year":"2017","unstructured":"Motyl KJ, Guntur AR, Carvalho AL, Rosen CJ. Energy metabolism of bone. Toxicol Pathol. 2017;45(7):887\u201393. https:\/\/doi.org\/10.1177\/0192623317737065.","journal-title":"Toxicol Pathol"},{"issue":"9","key":"10052_CR10","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/jbmr.417","volume":"26","author":"Y Yoshikawa","year":"2011","unstructured":"Yoshikawa Y, Kode A, Xu L, et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res. 2011;26(9):2012\u201325. https:\/\/doi.org\/10.1002\/jbmr.417.","journal-title":"J Bone Miner Res"},{"key":"10052_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1629273","volume":"16","author":"M Yuze","year":"2025","unstructured":"Yuze M, Hu J, Jun L, et al. Osteocytes function as biomechanical signaling hubs bridging mechanical stress sensing and systemic adaptation. Front Physiol. 2025;16:1629273. https:\/\/doi.org\/10.3389\/fphys.2025.1629273.","journal-title":"Front Physiol"},{"issue":"4","key":"10052_CR12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1210\/en.2015-1867","volume":"157","author":"CJ Cain","year":"2016","unstructured":"Cain CJ, Valencia JT, Ho S, et al. Increased Gs signaling in osteoblasts reduces bone marrow and whole-body adiposity in male mice. Endocrinology. 2016;157(4):1481\u201394. https:\/\/doi.org\/10.1210\/en.2015-1867.","journal-title":"Endocrinology"},{"key":"10052_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mce.2015.02.001","volume":"410","author":"ME McGee-Lawrence","year":"2015","unstructured":"McGee-Lawrence ME, White TA, LeBrasseur NK, Westendorf JJ. Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction. Mol Cell Endocrinol. 2015;410:42\u201351. https:\/\/doi.org\/10.1016\/j.mce.2015.02.001.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10052_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00880-7","volume":"18","author":"KJ Suchacki","year":"2020","unstructured":"Suchacki KJ, Morton NM, Vary C, et al. PHOSPHO1 is a skeletal regulator of insulin resistance and obesity. BMC Biol. 2020;18(1):149. https:\/\/doi.org\/10.1186\/s12915-020-00880-7.","journal-title":"BMC Biol"},{"key":"10052_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2018.03.012","volume":"119","author":"CP Hawkes","year":"2019","unstructured":"Hawkes CP, Mostoufi-Moab S. Fat-bone interaction within the bone marrow milieu: impact on hematopoiesis and systemic energy metabolism. Bone. 2019;119:57\u201364. https:\/\/doi.org\/10.1016\/j.bone.2018.03.012.","journal-title":"Bone"},{"key":"10052_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-physiol-021119-034513","volume":"82","author":"FJA de Paula","year":"2020","unstructured":"de Paula FJA, Rosen CJ. Marrow adipocytes: origin, structure, and function. Annu Rev Physiol. 2020;82:461\u201384. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034513.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10052_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2014.06.003","volume":"20","author":"WP Cawthorn","year":"2014","unstructured":"Cawthorn WP, Scheller EL, Learman BS, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014;20(2):368\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.003.","journal-title":"Cell Metab"},{"key":"10052_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117326","volume":"190","author":"L Liu","year":"2025","unstructured":"Liu L, Le PT, DeMambro VE, et al. Calorie restriction induces mandible bone loss by regulating mitochondrial function. Bone. 2025;190:117326. https:\/\/doi.org\/10.1016\/j.bone.2024.117326.","journal-title":"Bone"},{"issue":"1","key":"10052_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-025-00483-4","volume":"13","author":"H Liu","year":"2025","unstructured":"Liu H, Li B, Liu L, et al. Weight loss induced bone loss: mechanism of action and clinical implications. Bone Res. 2025;13(1):99. https:\/\/doi.org\/10.1038\/s41413-025-00483-4.","journal-title":"Bone Res"},{"key":"10052_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-nutr-061121-091348","volume":"43","author":"G Karsenty","year":"2023","unstructured":"Karsenty G. Osteocalcin: a multifaceted bone-derived hormone. Annu Rev Nutr. 2023;43:55\u201371. https:\/\/doi.org\/10.1146\/annurev-nutr-061121-091348.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"10052_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456\u201369. https:\/\/doi.org\/10.1016\/j.cell.2007.05.047.","journal-title":"Cell"},{"issue":"1","key":"10052_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-014-9931-y","volume":"96","author":"TC Brennan-Speranza","year":"2015","unstructured":"Brennan-Speranza TC, Conigrave AD. Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism. Calcif Tissue Int. 2015;96(1):1\u201310. https:\/\/doi.org\/10.1007\/s00223-014-9931-y.","journal-title":"Calcif Tissue Int"},{"issue":"13","key":"10052_CR23","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1073\/pnas.0711119105","volume":"105","author":"M Ferron","year":"2008","unstructured":"Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105(13):5266\u201370. https:\/\/doi.org\/10.1073\/pnas.0711119105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10052_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11154-014-9307-7","volume":"16","author":"J Wei","year":"2015","unstructured":"Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord. 2015;16(2):93\u20138. https:\/\/doi.org\/10.1007\/s11154-014-9307-7.","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10052_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00125-011-2155-z","volume":"54","author":"P Ducy","year":"2011","unstructured":"Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011;54(6):1291\u20137. https:\/\/doi.org\/10.1007\/s00125-011-2155-z.","journal-title":"Diabetologia"},{"issue":"2","key":"10052_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2010.06.003.","journal-title":"Cell"},{"issue":"6","key":"10052_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1530\/EJE-12-0030","volume":"166","author":"V Schwetz","year":"2012","unstructured":"Schwetz V, Pieber T, Obermayer-Pietsch B. The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol. 2012;166(6):959\u201367. https:\/\/doi.org\/10.1530\/EJE-12-0030.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10052_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jbmr.321","volume":"26","author":"TL Clemens","year":"2011","unstructured":"Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011;26(4):677\u201380. https:\/\/doi.org\/10.1002\/jbmr.321.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10052_CR29","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1074\/jbc.M111.282897","volume":"287","author":"A Kode","year":"2012","unstructured":"Kode A, Mosialou I, Silva BC, et al. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis. J Biol Chem. 2012;287(12):8757\u201368. https:\/\/doi.org\/10.1074\/jbc.M111.282897.","journal-title":"J Biol Chem"},{"issue":"4","key":"10052_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1172\/JCI75554","volume":"124","author":"RC Riddle","year":"2014","unstructured":"Riddle RC, Clemens TL. Insulin, osteoblasts, and energy metabolism: why bone counts calories. J Clin Invest. 2014;124(4):1465\u20137. https:\/\/doi.org\/10.1172\/JCI75554.","journal-title":"J Clin Invest"},{"key":"10052_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2015.05.046","volume":"82","author":"ML Zoch","year":"2016","unstructured":"Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone. 2016;82:42\u20139. https:\/\/doi.org\/10.1016\/j.bone.2015.05.046.","journal-title":"Bone"},{"issue":"3","key":"10052_CR32","doi-asserted-by":"publisher","first-page":"E381","DOI":"10.1152\/ajpendo.00321.2019","volume":"318","author":"J Lacombe","year":"2020","unstructured":"Lacombe J, Al Rifai O, Loter L, et al. Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and \u03b2-cell function. Am J Physiol Endocrinol Metab. 2020;318(3):E381\u201391. https:\/\/doi.org\/10.1152\/ajpendo.00321.2019.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10052_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.abb.2010.07.030","volume":"503","author":"KJ Motyl","year":"2010","unstructured":"Motyl KJ, McCabe LR, Schwartz AV. Bone and glucose metabolism: a two-way street. Arch Biochem Biophys. 2010;503(1):2\u201310. https:\/\/doi.org\/10.1016\/j.abb.2010.07.030.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10052_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1359\/jbmr.081234","volume":"24","author":"JM Kindblom","year":"2009","unstructured":"Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24(5):785\u201391. https:\/\/doi.org\/10.1359\/jbmr.081234.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10052_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7150\/ijms.7152","volume":"11","author":"KY Chin","year":"2014","unstructured":"Chin KY, Ima-Nirwana S, Mohamed IN, et al. Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int J Med Sci. 2014;11(2):151\u20137. https:\/\/doi.org\/10.7150\/ijms.7152.","journal-title":"Int J Med Sci"},{"issue":"3","key":"10052_CR36","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/j.orcp.2012.12.003","volume":"8","author":"GS Kim","year":"2014","unstructured":"Kim GS, Jekal Y, Kim HS, et al. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract. 2014;8(3):e201-98. https:\/\/doi.org\/10.1016\/j.orcp.2012.12.003.","journal-title":"Obes Res Clin Pract"},{"issue":"4","key":"10052_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/oby.20131","volume":"21","author":"CM Lenders","year":"2013","unstructured":"Lenders CM, Lee PD, Feldman HA, et al. A cross-sectional study of osteocalcin and body fat measures among obese adolescents. Obesity. 2013;21(4):808\u201314. https:\/\/doi.org\/10.1002\/oby.20131.","journal-title":"Obesity"},{"issue":"2","key":"10052_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2011.04031.x","volume":"75","author":"GY Rochefort","year":"2011","unstructured":"Rochefort GY, Rocher E, Aveline PC, et al. Osteocalcin-insulin relationship in obese children: a role for the skeleton in energy metabolism. Clin Endocrinol (Oxf). 2011;75(2):265\u201370. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04031.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10052_CR39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ijo.2009.282","volume":"34","author":"T Reinehr","year":"2010","unstructured":"Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010;34(5):852\u20138. https:\/\/doi.org\/10.1038\/ijo.2009.282.","journal-title":"Int J Obes (Lond)"},{"issue":"5\u20136","key":"10052_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1515\/jpem-2014-0432","volume":"28","author":"J Jurimae","year":"2015","unstructured":"Jurimae J, Latt E, Maestu J, et al. Osteocalcin is inversely associated with adiposity and leptin in adolescent boys. J Pediatr Endocrinol Metab. 2015;28(5\u20136):571\u20137. https:\/\/doi.org\/10.1515\/jpem-2014-0432.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10052_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.diabres.2011.03.015","volume":"92","author":"I Kanazawa","year":"2011","unstructured":"Kanazawa I, Yamaguchi T, Sugimoto T. Relationship between bone biochemical markers versus glucose\/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;92(3):393\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2011.03.015.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10052_CR42","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/oby.2012.108","volume":"20","author":"LE Polgreen","year":"2012","unstructured":"Polgreen LE, Jacobs DR Jr., Nathan BM, et al. Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity (Silver Spring). 2012;20(11):2194\u2013201. https:\/\/doi.org\/10.1038\/oby.2012.108.","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10052_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/GME.0b013e31828838e8","volume":"20","author":"S Kim","year":"2013","unstructured":"Kim S, Lee JY, Im JA, et al. Association between serum osteocalcin and insulin resistance in postmenopausal, but not premenopausal, women in Korea. Menopause. 2013;20(10):1061\u20136. https:\/\/doi.org\/10.1097\/GME.0b013e31828838e8.","journal-title":"Menopause"},{"issue":"2\u20133","key":"10052_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000370198","volume":"66","author":"XY Ma","year":"2015","unstructured":"Ma XY, Chen FQ, Hong H, et al. The relationship between serum osteocalcin concentration and glucose and lipid metabolism in patients with Type 2 diabetes mellitus - the role of osteocalcin in energy metabolism. Ann Nutr Metab. 2015;66(2\u20133):110\u20136. https:\/\/doi.org\/10.1159\/000370198.","journal-title":"Ann Nutr Metab"},{"issue":"8","key":"10052_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1515\/jpem-2015-0417","volume":"29","author":"J Takaya","year":"2016","unstructured":"Takaya J, Tanabe Y, Kuroyanagi Y, Kaneko K. Decreased undercarboxylated osteocalcin in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2016;29(8):879\u201384. https:\/\/doi.org\/10.1515\/jpem-2015-0417.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"10052_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01462-8","volume":"23","author":"VC Sharma","year":"2023","unstructured":"Sharma VC, Vidyasagar S, Sukumar CA, et al. Association between serum osteocalcin and atherosclerosis in Type-2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord. 2023;23(1):269. https:\/\/doi.org\/10.1186\/s12902-023-01462-8.","journal-title":"BMC Endocr Disord"},{"key":"10052_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101426","author":"A Tacey","year":"2018","unstructured":"Tacey A, Qaradakhi T, Brennan-Speranza T, et al. Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10101426.","journal-title":"Nutrients"},{"issue":"4","key":"10052_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/andr.12359","volume":"5","author":"L De Toni","year":"2017","unstructured":"De Toni L, Di Nisio A, Rocca MS, et al. Osteocalcin, a bone-derived hormone with important andrological implications. Andrology. 2017;5(4):664\u201370. https:\/\/doi.org\/10.1111\/andr.12359.","journal-title":"Andrology"},{"key":"10052_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.898645","volume":"13","author":"WB Zheng","year":"2022","unstructured":"Zheng WB, Hu J, Zhao DC, et al. The role of osteocalcin in regulation of glycolipid metabolism and muscle function in children with osteogenesis imperfecta. Front Endocrinol (Lausanne). 2022;13:898645. https:\/\/doi.org\/10.3389\/fendo.2022.898645.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10052_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1646558","volume":"16","author":"N Kang","year":"2025","unstructured":"Kang N, Huang J, Han X, et al. The role of osteocalcin in regulating the acute stress response. Front Pharmacol. 2025;16:1646558. https:\/\/doi.org\/10.3389\/fphar.2025.1646558.","journal-title":"Front Pharmacol"},{"issue":"18","key":"10052_CR51","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.4239\/wjd.v6.i18.1345","volume":"6","author":"I Kanazawa","year":"2015","unstructured":"Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes. 2015;6(18):1345\u201354. https:\/\/doi.org\/10.4239\/wjd.v6.i18.1345.","journal-title":"World J Diabetes"},{"issue":"2","key":"10052_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","volume":"50","author":"M Ferron","year":"2012","unstructured":"Ferron M, McKee MD, Levine RL, et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50(2):568\u201375. https:\/\/doi.org\/10.1016\/j.bone.2011.04.017.","journal-title":"Bone"},{"issue":"3","key":"10052_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.cellsig.2014.12.018","volume":"27","author":"T Otani","year":"2015","unstructured":"Otani T, Mizokami A, Hayashi Y, et al. Signaling pathway for adiponectin expression in adipocytes by osteocalcin. Cell Signal. 2015;27(3):532\u201344. https:\/\/doi.org\/10.1016\/j.cellsig.2014.12.018.","journal-title":"Cell Signal"},{"issue":"2","key":"10052_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/JOE-19-0288","volume":"244","author":"A Mizokami","year":"2020","unstructured":"Mizokami A, Mukai S, Gao J, et al. GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin. J Endocrinol. 2020;244(2):285\u201396. https:\/\/doi.org\/10.1530\/JOE-19-0288.","journal-title":"J Endocrinol"},{"key":"10052_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.001","volume":"132","author":"A Mizokami","year":"2017","unstructured":"Mizokami A, Kawakubo-Yasukochi T, Hirata M. Osteocalcin and its endocrine functions. Biochem Pharmacol. 2017;132:1\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2017.02.001.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10052_CR56","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/joim.12348","volume":"277","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Riddle RC, Clemens TL. Bone and the regulation of global energy balance. J Intern Med. 2015;277(6):681\u20139. https:\/\/doi.org\/10.1111\/joim.12348.","journal-title":"J Intern Med"},{"key":"10052_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.abb.2014.05.022","volume":"561","author":"M Ferron","year":"2014","unstructured":"Ferron M, Lacombe J. Regulation of energy metabolism by the skeleton: osteocalcin and beyond. Arch Biochem Biophys. 2014;561:137\u201346. https:\/\/doi.org\/10.1016\/j.abb.2014.05.022.","journal-title":"Arch Biochem Biophys"},{"key":"10052_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bone.2017.11.020","volume":"115","author":"JAC Guedes","year":"2018","unstructured":"Guedes JAC, Esteves JV, Morais MR, et al. Osteocalcin improves insulin resistance and inflammation in obese mice: participation of white adipose tissue and bone. Bone. 2018;115:68\u201382. https:\/\/doi.org\/10.1016\/j.bone.2017.11.020.","journal-title":"Bone"},{"issue":"12","key":"10052_CR59","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.4161\/cc.24929","volume":"12","author":"B Zhou","year":"2013","unstructured":"Zhou B, Li H, Liu J, et al. Intermittent injections of osteocalcin reverse autophagic dysfunction and endoplasmic reticulum stress resulting from diet-induced obesity in the vascular tissue via the NF\u03baB-p65-dependent mechanism. Cell Cycle. 2013;12(12):1901\u201313. https:\/\/doi.org\/10.4161\/cc.24929.","journal-title":"Cell Cycle"},{"issue":"5","key":"10052_CR60","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/ijo.2016.1","volume":"40","author":"B Zhou","year":"2016","unstructured":"Zhou B, Li H, Liu J, et al. Autophagic dysfunction is improved by intermittent administration of osteocalcin in obese mice. Int J Obes (Lond). 2016;40(5):833\u201343. https:\/\/doi.org\/10.1038\/ijo.2016.1.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10052_CR61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41401-019-0311-z","volume":"41","author":"XL Zhang","year":"2020","unstructured":"Zhang XL, Wang YN, Ma LY, et al. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacol Sin. 2020;41(3):383\u201393. https:\/\/doi.org\/10.1038\/s41401-019-0311-z.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"10052_CR62","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1210\/en.2014-1430","volume":"155","author":"AA Gupte","year":"2014","unstructured":"Gupte AA, Sabek OM, Fraga D, et al. Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome. Endocrinology. 2014;155(12):4697\u2013705. https:\/\/doi.org\/10.1210\/en.2014-1430.","journal-title":"Endocrinology"},{"key":"10052_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073121","author":"D Wang","year":"2023","unstructured":"Wang D, Zhang M, Xu J, Yang J. Uncarboxylated osteocalcin decreases SCD1 by activating AMPK to alleviate hepatocyte lipid accumulation. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28073121.","journal-title":"Molecules"},{"issue":"5","key":"10052_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-0034-1368709","volume":"46","author":"HS Hill","year":"2014","unstructured":"Hill HS, Grams J, Walton RG, et al. Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res. 2014;46(5):341\u20137. https:\/\/doi.org\/10.1055\/s-0034-1368709.","journal-title":"Horm Metab Res"},{"issue":"8","key":"10052_CR65","doi-asserted-by":"publisher","first-page":"E662","DOI":"10.1152\/ajpendo.00334.2015","volume":"310","author":"Y Yasutake","year":"2016","unstructured":"Yasutake Y, Mizokami A, Kawakubo-Yasukochi T, et al. Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet. Am J Physiol Endocrinol Metab. 2016;310(8):E662\u201375. https:\/\/doi.org\/10.1152\/ajpendo.00334.2015.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10052_CR66","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bone.2011.06.032","volume":"50","author":"B Lecka-Czernik","year":"2012","unstructured":"Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 2012;50(2):534\u20139. https:\/\/doi.org\/10.1016\/j.bone.2011.06.032.","journal-title":"Bone"},{"issue":"13","key":"10052_CR67","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s00018-012-1211-2","volume":"70","author":"H Sadie-Van Gijsen","year":"2013","unstructured":"Sadie-Van Gijsen H, Crowther NJ, Hough FS, Ferris WF. The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol Life Sci. 2013;70(13):2331\u201349. https:\/\/doi.org\/10.1007\/s00018-012-1211-2.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10052_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/21623945.2016.1149269","volume":"5","author":"EL Scheller","year":"2016","unstructured":"Scheller EL, Burr AA, MacDougald OA, Cawthorn WP. Inside out: bone marrow adipose tissue as a source of circulating adiponectin. Adipocyte. 2016;5(3):251\u201369.","journal-title":"Adipocyte"},{"issue":"1","key":"10052_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2265.2003.01702.x","volume":"58","author":"ML Delporte","year":"2003","unstructured":"Delporte ML, Brichard SM, Hermans MP, et al. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003;58(1):22\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10052_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2337\/diabetes.52.2.268","volume":"52","author":"TP Combs","year":"2003","unstructured":"Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003;52(2):268\u201376.","journal-title":"Diabetes"},{"issue":"4","key":"10052_CR71","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.clnu.2020.10.034","volume":"40","author":"HV Kord","year":"2021","unstructured":"Kord HV, Tinsley GM, Santos HO, et al. The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis. Clin Nutr. 2021;40(4):1811\u201321. https:\/\/doi.org\/10.1016\/j.clnu.2020.10.034.","journal-title":"Clin Nutr"},{"key":"10052_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00128","volume":"7","author":"RJ Sulston","year":"2016","unstructured":"Sulston RJ, Learman BS, Zhang B, et al. Increased circulating adiponectin in response to thiazolidinediones: Investigating the role of bone marrow adipose tissue. Front Endocrinol (Lausanne). 2016;7:128. https:\/\/doi.org\/10.3389\/fendo.2016.00128.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"25","key":"10052_CR73","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1161\/CIRCULATIONAHA.112.135202","volume":"126","author":"JR Kizer","year":"2012","unstructured":"Kizer JR, Benkeser D, Arnold AM, et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation. 2012;126(25):2951\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.135202.","journal-title":"Circulation"},{"issue":"10","key":"10052_CR74","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/jbmr.4394","volume":"36","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu P, Ling S, et al. Forkhead box P1 (Foxp1) in osteoblasts regulates bone mass accrual and adipose tissue energy metabolism. J Bone Min Res. 2021;36(10):2017\u201326. https:\/\/doi.org\/10.1002\/jbmr.4394.","journal-title":"J Bone Min Res"},{"issue":"Pt 23","key":"10052_CR75","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.1242\/jcs.134510","volume":"126","author":"A Bozec","year":"2013","unstructured":"Bozec A, Bakiri L, Jimenez M, et al. Osteoblast-specific expression of Fra-2\/AP-1 controls adiponectin and osteocalcin expression and affects metabolism. J Cell Sci. 2013;126(Pt 23):5432\u201340. https:\/\/doi.org\/10.1242\/jcs.134510.","journal-title":"J Cell Sci"},{"issue":"3","key":"10052_CR76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/JOE-15-0225","volume":"226","author":"I Kaneko","year":"2015","unstructured":"Kaneko I, Saini RK, Griffin KP, et al. FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes. J Endocrinol. 2015;226(3):155\u201366. https:\/\/doi.org\/10.1530\/JOE-15-0225.","journal-title":"J Endocrinol"},{"issue":"8","key":"10052_CR77","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jbmr.65","volume":"25","author":"K Tsuji","year":"2010","unstructured":"Tsuji K, Maeda T, Kawane T, et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J Bone Min Res. 2010;25(8):1711\u201323. https:\/\/doi.org\/10.1002\/jbmr.65.","journal-title":"J Bone Min Res"},{"issue":"2","key":"10052_CR78","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","volume":"26","author":"M Hesse","year":"2007","unstructured":"Hesse M, Frohlich LF, Zeitz U, et al. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol. 2007;26(2):75\u201384. https:\/\/doi.org\/10.1016\/j.matbio.2006.10.003.","journal-title":"Matrix Biol"},{"issue":"1","key":"10052_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","volume":"31","author":"MA Mirza","year":"2011","unstructured":"Mirza MA, Alsio J, Hammarstedt A, et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol. 2011;31(1):219\u201327. https:\/\/doi.org\/10.1161\/ATVBAHA.110.214619.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10052_CR80","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1152\/japplphysiol.00838.2018","volume":"126","author":"JM Hum","year":"2019","unstructured":"Hum JM, O\u2019Bryan LM, Tatiparthi AK, et al. Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy. J Appl Physiol (1985). 2019;126(4):854\u201362. https:\/\/doi.org\/10.1152\/japplphysiol.00838.2018.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10052_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1615\/critreveukargeneexpr.v22.i1.50","volume":"22","author":"PS Rowe","year":"2012","unstructured":"Rowe PS. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr. 2012;22(1):61\u201386. https:\/\/doi.org\/10.1615\/critreveukargeneexpr.v22.i1.50.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"10052_CR82","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin A, David V, Quarles LD. Regulation and function of the FGF23\/klotho endocrine pathways. Physiol Rev. 2012;92(1):131\u201355. https:\/\/doi.org\/10.1152\/physrev.00002.2011.","journal-title":"Physiol Rev"},{"issue":"2","key":"10052_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.15171\/jrip.2016.22","volume":"5","author":"F Yaghoubi","year":"2016","unstructured":"Yaghoubi F, Ahmadi F, Lesanpezeshki M, Mahdavi Mazde M. A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis. J Renal Inj Prev. 2016;5(2):104\u20137. https:\/\/doi.org\/10.15171\/jrip.2016.22.","journal-title":"J Renal Inj Prev"},{"issue":"4","key":"10052_CR84","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1210\/en.2011-1878","volume":"153","author":"C Streicher","year":"2012","unstructured":"Streicher C, Zeitz U, Andrukhova O, et al. Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor. Endocrinology. 2012;153(4):1795\u2013805. https:\/\/doi.org\/10.1210\/en.2011-1878.","journal-title":"Endocrinology"},{"issue":"5","key":"10052_CR85","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3349\/ymj.2007.48.5.765","volume":"48","author":"JJ An","year":"2007","unstructured":"An JJ, Han DH, Kim DM, et al. Expression and regulation of osteoprotegerin in adipose tissue. Yonsei Med J. 2007;48(5):765\u201372. https:\/\/doi.org\/10.3349\/ymj.2007.48.5.765.","journal-title":"Yonsei Med J"},{"issue":"1\u20132","key":"10052_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2014.06.004","volume":"394","author":"S Bernardi","year":"2014","unstructured":"Bernardi S, Fabris B, Thomas M, et al. Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes. Mol Cell Endocrinol. 2014;394(1\u20132):13\u201320. https:\/\/doi.org\/10.1016\/j.mce.2014.06.004.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10052_CR87","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2310\/6650.2006.06019","volume":"54","author":"Y Tintut","year":"2006","unstructured":"Tintut Y, Demer L. Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification. J Investig Med. 2006;54(7):395\u2013401. https:\/\/doi.org\/10.2310\/6650.2006.06019.","journal-title":"J Investig Med"},{"issue":"8","key":"10052_CR88","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E, et al. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest. 2019;129(8):3214\u201323. https:\/\/doi.org\/10.1172\/JCI125915.","journal-title":"J Clin Invest"},{"issue":"1","key":"10052_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2015.05.021","volume":"22","author":"NG Kondegowda","year":"2015","unstructured":"Kondegowda NG, Fenutria R, Pollack IR, et al. Osteoprotegerin and Denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-\u03baB ligand pathway. Cell Metab. 2015;22(1):77\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.021.","journal-title":"Cell Metab"},{"key":"10052_CR90","doi-asserted-by":"publisher","DOI":"10.1177\/20420188231170754","volume":"14","author":"B Xing","year":"2023","unstructured":"Xing B, Yu J, Zhang H, Li Y. RANKL inhibition: a new target of treating diabetes mellitus? Ther Adv Endocrinol Metab. 2023;14:20420188231170754. https:\/\/doi.org\/10.1177\/20420188231170754.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"10052_CR91","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","volume":"19","author":"S Kiechl","year":"2013","unstructured":"Kiechl S, Wittmann J, Giaccari A, et al. Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med. 2013;19(3):358\u201363. https:\/\/doi.org\/10.1038\/nm.3084.","journal-title":"Nat Med"},{"issue":"6","key":"10052_CR92","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2016.02.043","volume":"164","author":"G Karsenty","year":"2016","unstructured":"Karsenty G, Olson EN. Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell. 2016;164(6):1248\u201356. https:\/\/doi.org\/10.1016\/j.cell.2016.02.043.","journal-title":"Cell"},{"issue":"1","key":"10052_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14003-6","volume":"11","author":"MM Weivoda","year":"2020","unstructured":"Weivoda MM, Chew CK, Monroe DG, et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat Commun. 2020;11(1):87. https:\/\/doi.org\/10.1038\/s41467-019-14003-6.","journal-title":"Nat Commun"},{"issue":"2","key":"10052_CR94","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00223-015-0075-5","volume":"98","author":"A Lasco","year":"2016","unstructured":"Lasco A, Morabito N, Basile G, et al. Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis. Calcif Tissue Int. 2016;98(2):123\u20138. https:\/\/doi.org\/10.1007\/s00223-015-0075-5.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"10052_CR95","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1210\/jc.2013-4440","volume":"99","author":"BZ Leder","year":"2014","unstructured":"Leder BZ, Tsai JN, Uihlein AV, et al. Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial. J Clin Endocrinol Metab. 2014;99(5):1694\u2013700. https:\/\/doi.org\/10.1210\/jc.2013-4440.","journal-title":"J Clin Endocrinol Metab"},{"key":"10052_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/352858","volume":"2015","author":"E Passeri","year":"2015","unstructured":"Passeri E, Benedini S, Costa E, Corbetta S. A single 60 mg dose of Denosumab might improve hepatic insulin sensitivity in postmenopausal nondiabetic severe osteoporotic women. Int J Endocrinol. 2015;2015:352858. https:\/\/doi.org\/10.1155\/2015\/352858.","journal-title":"Int J Endocrinol"},{"key":"10052_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1809150","volume":"2020","author":"A Rossini","year":"2020","unstructured":"Rossini A, Frigerio S, Dozio E, et al. Effect of Denosumab on glucose homeostasis in postmenopausal women with breast cancer treated with aromatase inhibitors: a pilot study. Int J Endocrinol. 2020;2020:1809150. https:\/\/doi.org\/10.1155\/2020\/1809150.","journal-title":"Int J Endocrinol"},{"issue":"47","key":"10052_CR98","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018067","volume":"98","author":"I Abe","year":"2019","unstructured":"Abe I, Ochi K, Takashi Y, et al. Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: effect of denosumab on glycemic parameters. Medicine (Baltimore). 2019;98(47):e18067. https:\/\/doi.org\/10.1097\/MD.0000000000018067.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10052_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2991","volume":"34","author":"N Napoli","year":"2018","unstructured":"Napoli N, Pannacciulli N, Vittinghoff E, et al. Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial. Diabetes Metab Res Rev. 2018;34(4):e2991. https:\/\/doi.org\/10.1002\/dmrr.2991.","journal-title":"Diabetes Metab Res Rev"},{"key":"10052_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073435","volume":"381","author":"H Lyu","year":"2023","unstructured":"Lyu H, Zhao SS, Zhang L, et al. Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study. BMJ. 2023;381:e073435. https:\/\/doi.org\/10.1136\/bmj-2022-073435.","journal-title":"BMJ"},{"issue":"2","key":"10052_CR101","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.54734","volume":"7","author":"HK Huang","year":"2024","unstructured":"Huang HK, Chuang AT, Liao TC, et al. Denosumab and the risk of diabetes in patients treated for osteoporosis. JAMA Netw Open. 2024;7(2):e2354734. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54734.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10052_CR102","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00198-024-07182-6","volume":"35","author":"W Rathmann","year":"2024","unstructured":"Rathmann W, Kostev K. Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study. Osteoporos Int. 2024;35(12):2099\u2013106. https:\/\/doi.org\/10.1007\/s00198-024-07182-6.","journal-title":"Osteoporos Int"},{"issue":"9","key":"10052_CR103","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1111\/dom.15708","volume":"26","author":"AE Henney","year":"2024","unstructured":"Henney AE, Riley DR, O\u2019Connor B, et al. Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis. Diabetes Obes Metab. 2024;26(9):3673\u201383. https:\/\/doi.org\/10.1111\/dom.15708.","journal-title":"Diabetes Obes Metab"},{"key":"10052_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030331","author":"L Meng","year":"2025","unstructured":"Meng L, Sun L, Li M. Research progress on the influence of novel targeted drugs for osteoporosis on glucose metabolism. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15030331.","journal-title":"Biomolecules"},{"key":"10052_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050406","author":"H Liu","year":"2024","unstructured":"Liu H, Liu L, Rosen CJ. PTH and the regulation of mesenchymal cells within the bone marrow niche. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13050406.","journal-title":"Cells"},{"issue":"2","key":"10052_CR106","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/cdd.2016.113","volume":"24","author":"X Zhang","year":"2017","unstructured":"Zhang X, Cheng Q, Wang Y, et al. Hedgehog signaling in bone regulates whole-body energy metabolism through a bone-adipose endocrine relay mediated by PTHrP and adiponectin. Cell Death Differ. 2017;24(2):225\u201337. https:\/\/doi.org\/10.1038\/cdd.2016.113.","journal-title":"Cell Death Differ"},{"issue":"1","key":"10052_CR107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1507\/endocrj.EJ20-0728","volume":"69","author":"B Qin","year":"2022","unstructured":"Qin B, Qincao L, He S, et al. Parathyroid hormone-related protein prevents high-fat-diet-induced obesity, hepatic steatosis and insulin resistance in mice. Endocr J. 2022;69(1):55\u201365. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0728.","journal-title":"Endocr J"},{"issue":"11","key":"10052_CR108","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1210\/endo.142.11.8515","volume":"142","author":"GK Chan","year":"2001","unstructured":"Chan GK, Deckelbaum RA, Bolivar I, et al. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology. 2001;142(11):4900\u20139. https:\/\/doi.org\/10.1210\/endo.142.11.8515.","journal-title":"Endocrinology"},{"key":"10052_CR109","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031666","author":"P Mera","year":"2018","unstructured":"Mera P, Ferron M, Mosialou I. Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a031666.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10052_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13504","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu J, Kousteni S. Lipocalin 2-a bone-derived anorexigenic and beta-cell promoting signal: from mice to humans. J Diabetes. 2024;16(3):e13504. https:\/\/doi.org\/10.1111\/1753-0407.13504.","journal-title":"J Diabetes"},{"issue":"1","key":"10052_CR111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12933-018-0786-9","volume":"17","author":"Y Xu","year":"2018","unstructured":"Xu Y, Ma X, Pan X, et al. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women. Cardiovasc Diabetol. 2018;17(1):143. https:\/\/doi.org\/10.1186\/s12933-018-0786-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"7645","key":"10052_CR112","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature21697","volume":"543","author":"I Mosialou","year":"2017","unstructured":"Mosialou I, Shikhel S, Liu JM, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature. 2017;543(7645):385\u201390. https:\/\/doi.org\/10.1038\/nature21697.","journal-title":"Nature"},{"key":"10052_CR113","doi-asserted-by":"publisher","unstructured":"Petropoulou PI, Mosialou I, Shikhel S, et al. Lipocalin-2 is an anorexigenic signal in primates. Elife. 2020;9. https:\/\/doi.org\/10.7554\/eLife.58949.","DOI":"10.7554\/eLife.58949"},{"issue":"4","key":"10052_CR114","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"IKM Law","year":"2010","unstructured":"Law IKM, Xu A, Lam KSL, et al. Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity. Diabetes. 2010;59(4):872\u201382. https:\/\/doi.org\/10.2337\/db09-1541.","journal-title":"Diabetes"},{"key":"10052_CR115","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191261","author":"I Mosialou","year":"2020","unstructured":"Mosialou I, Shikhel S, Luo N, et al. Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191261.","journal-title":"J Exp Med"},{"issue":"1","key":"10052_CR116","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53(1):34\u201341. https:\/\/doi.org\/10.1373\/clinchem.2006.075614.","journal-title":"Clin Chem"},{"issue":"5","key":"10052_CR117","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4196\/kjpp.2019.23.5.335","volume":"23","author":"KA Park","year":"2019","unstructured":"Park KA, Jin Z, An HS, et al. Effects of caloric restriction on the expression of lipocalin-2 and its receptor in the brown adipose tissue of high-fat diet-fed mice. Korean J Physiol Pharmacol. 2019;23(5):335\u201344. https:\/\/doi.org\/10.4196\/kjpp.2019.23.5.335.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"6","key":"10052_CR118","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/db09-1735","volume":"59","author":"H Guo","year":"2010","unstructured":"Guo H, Jin D, Zhang Y, et al. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes. 2010;59(6):1376\u201385. https:\/\/doi.org\/10.2337\/db09-1735.","journal-title":"Diabetes"},{"issue":"8","key":"10052_CR119","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1515\/jpem-2021-0216","volume":"34","author":"J Takaya","year":"2021","unstructured":"Takaya J, Tanabe Y, Kaneko K. Increased lipocalin 2 levels in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2021;34(8):979\u201385. https:\/\/doi.org\/10.1515\/jpem-2021-0216.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"10052_CR120","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbamcr.2012.06.014","volume":"1823","author":"N Paragas","year":"2012","unstructured":"Paragas N, Qiu A, Hollmen M, et al. NGAL-Siderocalin in kidney disease. Biochim Biophys Acta. 2012;1823(9):1451\u20138. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.06.014.","journal-title":"Biochim Biophys Acta"},{"issue":"32","key":"10052_CR121","doi-asserted-by":"publisher","first-page":"22063","DOI":"10.1074\/jbc.M114.559104","volume":"289","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Guo H, Deis JA, et al. Lipocalin 2 regulates brown fat activation via a nonadrenergic activation mechanism. J Biol Chem. 2014;289(32):22063\u201377. https:\/\/doi.org\/10.1074\/jbc.M114.559104.","journal-title":"J Biol Chem"},{"issue":"12","key":"10052_CR122","doi-asserted-by":"publisher","first-page":"E640","DOI":"10.1002\/oby.20507","volume":"21","author":"CM Paton","year":"2013","unstructured":"Paton CM, Rogowski MP, Kozimor AL, et al. Lipocalin-2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women. Obes (Silver Spring). 2013;21(12):E640\u20138. https:\/\/doi.org\/10.1002\/oby.20507.","journal-title":"Obes (Silver Spring)"},{"issue":"51","key":"10052_CR123","doi-asserted-by":"publisher","first-page":"32584","DOI":"10.1073\/pnas.1922169117","volume":"117","author":"X Li","year":"2020","unstructured":"Li X, Zhang D, Vatner DF, et al. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proc Natl Acad Sci U S A. 2020;117(51):32584\u201393. https:\/\/doi.org\/10.1073\/pnas.1922169117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10052_CR124","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.18632\/aging.102263","volume":"11","author":"T Chen","year":"2019","unstructured":"Chen T, Zhang Y, Liu Y, et al. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-\u03b3-mediated PI3K\/AKT signaling. Aging (Albany NY). 2019;11(18):7510\u201324. https:\/\/doi.org\/10.18632\/aging.102263.","journal-title":"Aging (Albany NY)"},{"issue":"23","key":"10052_CR125","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003;22(23):6267\u201376. https:\/\/doi.org\/10.1093\/emboj\/cdg599.","journal-title":"EMBO J"},{"issue":"2","key":"10052_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179\u201392. https:\/\/doi.org\/10.1038\/nm.3074.","journal-title":"Nat Med"},{"key":"10052_CR127","doi-asserted-by":"publisher","first-page":"115694","DOI":"10.1016\/j.bcp.2023.115694","volume":"215","author":"H Jiang","year":"2023","unstructured":"Jiang H, Li D, Han Y, et al. The role of sclerostin in lipid and glucose metabolism disorders. Biochem Pharmacol. 2023;215:115694. https:\/\/doi.org\/10.1016\/j.bcp.2023.115694.","journal-title":"Biochem Pharmacol"},{"key":"10052_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.584147","volume":"12","author":"JS Wang","year":"2021","unstructured":"Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: candidate bone-produced hormones. Front Endocrinol (Lausanne). 2021;12:584147. https:\/\/doi.org\/10.3389\/fendo.2021.584147.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10052_CR129","doi-asserted-by":"publisher","first-page":"E2584","DOI":"10.1210\/jc.2013-4493","volume":"99","author":"YH Ma","year":"2014","unstructured":"Ma YH, Schwartz AV, Sigurdsson S, et al. Circulating sclerostin associated with vertebral bone marrow fat in older men but not women. J Clin Endocrinol Metab. 2014;99(12):E2584-90. https:\/\/doi.org\/10.1210\/jc.2013-4493.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10052_CR130","doi-asserted-by":"publisher","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","volume":"97","author":"T Urano","year":"2012","unstructured":"Urano T, Shiraki M, Ouchi Y, Inoue S. Association of circulating sclerostin levels with fat mass and metabolic disease\u2013related markers in Japanese postmenopausal women. J Clin Endocrinol Metab. 2012;97(8):E1473\u20137. https:\/\/doi.org\/10.1210\/jc.2012-1218.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10052_CR131","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2265.2011.04315.x","volume":"76","author":"Z Sheng","year":"2012","unstructured":"Sheng Z, Tong D, Ou Y, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2012;76(6):797\u2013801. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04315.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10052_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115053","volume":"128","author":"JA Kim","year":"2019","unstructured":"Kim JA, Roh E, Hong SH, et al. Association of serum sclerostin levels with low skeletal muscle mass: the Korean Sarcopenic Obesity Study (KSOS). Bone. 2019;128:115053. https:\/\/doi.org\/10.1016\/j.bone.2019.115053.","journal-title":"Bone"},{"issue":"1","key":"10052_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000497113","volume":"91","author":"J Stanik","year":"2019","unstructured":"Stanik J, Kratzsch J, Landgraf K, et al. The bone markers sclerostin, osteoprotegerin, and bone-specific alkaline phosphatase are related to insulin resistance in children and adolescents, independent of their association with growth and obesity. Horm Res Paediatr. 2019;91(1):1\u20138. https:\/\/doi.org\/10.1159\/000497113.","journal-title":"Horm Res Paediatr"},{"issue":"52","key":"10052_CR134","doi-asserted-by":"publisher","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","volume":"114","author":"SP Kim","year":"2017","unstructured":"Kim SP, Frey JL, Li Z, et al. Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes. Proc Natl Acad Sci U S A. 2017;114(52):E11238\u201347. https:\/\/doi.org\/10.1073\/pnas.1707876115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10052_CR135","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/jcp.25976","volume":"233","author":"H Fairfield","year":"2018","unstructured":"Fairfield H, Falank C, Harris E, et al. The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis. J Cell Physiol. 2018;233(2):1156\u201367. https:\/\/doi.org\/10.1002\/jcp.25976.","journal-title":"J Cell Physiol"},{"issue":"6","key":"10052_CR136","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/jcb.25432","volume":"117","author":"M Ukita","year":"2016","unstructured":"Ukita M, Yamaguchi T, Ohata N, Tamura M. Sclerostin enhances adipocyte differentiation in 3T3-L1 cells. J Cell Biochem. 2016;117(6):1419\u201328. https:\/\/doi.org\/10.1002\/jcb.25432.","journal-title":"J Cell Biochem"},{"issue":"4","key":"10052_CR137","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/cen.13300","volume":"86","author":"OH Yu","year":"2017","unstructured":"Yu OH, Richards B, Berger C, et al. The association between sclerostin and incident type 2 diabetes risk: a cohort study. Clin Endocrinol (Oxf). 2017;86(4):520\u20135. https:\/\/doi.org\/10.1111\/cen.13300.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10052_CR138","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1210\/jc.2011-2958","volume":"97","author":"L Gennari","year":"2012","unstructured":"Gennari L, Merlotti D, Valenti R, et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012;97(5):1737\u201344. https:\/\/doi.org\/10.1210\/jc.2011-2958.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10052_CR139","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/EJE-14-0106","volume":"171","author":"A Catalano","year":"2014","unstructured":"Catalano A, Pintaudi B, Morabito N, et al. Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus. Eur J Endocrinol. 2014;171(3):293\u2013300. https:\/\/doi.org\/10.1530\/EJE-14-0106.","journal-title":"Eur J Endocrinol"},{"key":"10052_CR140","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4596920","volume":"2020","author":"MC Medeiros","year":"2020","unstructured":"Medeiros MC, Rocha N, Bandeira E, et al. Serum Sclerostin, body composition, and sarcopenia in hemodialysis patients with diabetes. Int J Nephrol. 2020;2020:4596920. https:\/\/doi.org\/10.1155\/2020\/4596920.","journal-title":"Int J Nephrol"},{"issue":"2","key":"10052_CR141","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","volume":"56","author":"MS Ardawi","year":"2013","unstructured":"Ardawi MS, Akhbar DH, Alshaikh A, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone. 2013;56(2):355\u201362. https:\/\/doi.org\/10.1016\/j.bone.2013.06.029.","journal-title":"Bone"},{"issue":"1","key":"10052_CR142","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/jc.2011-2186","volume":"97","author":"A Garcia-Martin","year":"2012","unstructured":"Garcia-Martin A, Rozas-Moreno P, Reyes-Garcia R, et al. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97(1):234\u201341. https:\/\/doi.org\/10.1210\/jc.2011-2186.","journal-title":"J Clin Endocrinol Metab"},{"key":"10052_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020623","author":"F Carbone","year":"2021","unstructured":"Carbone F, Nulli Migliola E, Bonaventura A, et al. Circulating levels of Sclerostin predict glycemic improvement after sleeve gastrectomy. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13020623.","journal-title":"Nutrients"},{"issue":"5","key":"10052_CR144","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.apsb.2022.01.012","volume":"12","author":"S Yu","year":"2022","unstructured":"Yu S, Li D, Zhang N, et al. Drug discovery of sclerostin inhibitors. Acta Pharm Sin B. 2022;12(5):2150\u201370. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.012.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10052_CR145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jbmr.3001","volume":"32","author":"K Fulzele","year":"2017","unstructured":"Fulzele K, Lai F, Dedic C, et al. Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots. J Bone Miner Res. 2017;32(2):373\u201384. https:\/\/doi.org\/10.1002\/jbmr.3001.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10052_CR146","doi-asserted-by":"publisher","first-page":"e21957","DOI":"10.1096\/fj.202100691R","volume":"35","author":"SP Kim","year":"2021","unstructured":"Kim SP, Da H, Wang L, et al. Bone-derived sclerostin and Wnt\/beta-catenin signaling regulate PDGFRalpha(+) adipoprogenitor cell differentiation. FASEB J. 2021;35(11):e21957. https:\/\/doi.org\/10.1096\/fj.202100691R.","journal-title":"FASEB J"},{"issue":"17","key":"10052_CR147","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1074\/jbc.RA118.006769","volume":"294","author":"SP Kim","year":"2019","unstructured":"Kim SP, Da H, Li Z, et al. Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin\u2019s endocrine effects on body composition and glucose metabolism. J Biol Chem. 2019;294(17):6899\u2013911. https:\/\/doi.org\/10.1074\/jbc.RA118.006769.","journal-title":"J Biol Chem"},{"issue":"2","key":"10052_CR148","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3803\/EnM.2023.1673","volume":"38","author":"L Liu","year":"2023","unstructured":"Liu L, Rosen CJ. New insights into calorie restriction induced bone loss. Endocrinology and Metabolism. 2023;38(2):203\u201313. https:\/\/doi.org\/10.3803\/EnM.2023.1673.","journal-title":"Endocrinology and Metabolism"},{"key":"10052_CR149","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69209","volume":"10","author":"N Aaron","year":"2021","unstructured":"Aaron N, Kraakman MJ, Zhou Q, et al. Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells. Elife. 2021;10:e69209. https:\/\/doi.org\/10.7554\/eLife.69209.","journal-title":"Elife"},{"issue":"8","key":"10052_CR150","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jbmr\/zjae104","volume":"39","author":"L Liu","year":"2024","unstructured":"Liu L, Le PT, Stohn JP, et al. Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling. J Bone Miner Res. 2024;39(8):1188\u201399. https:\/\/doi.org\/10.1093\/jbmr\/zjae104.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10052_CR151","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1002\/jcp.24064","volume":"227","author":"K Baek","year":"2012","unstructured":"Baek K, Cho JY, Hwang HR, et al. Myeloid Elf\u20101\u2010like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator\u2010activated receptor \u03b3 expression in bone marrow. J Cell Physiol. 2012;227(11):3603\u201312. https:\/\/doi.org\/10.1002\/jcp.24064.","journal-title":"J Cell Physiol"},{"issue":"3","key":"10052_CR152","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cmet.2016.01.008","volume":"23","author":"KJ Svensson","year":"2016","unstructured":"Svensson KJ, Long JZ, Jedrychowski MP, et al. A secreted Slit2 fragment regulates adipose tissue thermogenesis and metabolic function. Cell Metab. 2016;23(3):454\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.008.","journal-title":"Cell Metab"},{"issue":"1","key":"10052_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51155-6","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Shi B, Li N, et al. Bone controls browning of white adipose tissue and protects from diet-induced obesity through Schnurri-3-regulated SLIT2 secretion. Nat Commun. 2024;15(1):6697. https:\/\/doi.org\/10.1038\/s41467-024-51155-6.","journal-title":"Nat Commun"},{"issue":"4","key":"10052_CR154","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1096\/fj.14-261891","volume":"29","author":"E Rodriguez-Carballo","year":"2015","unstructured":"Rodriguez-Carballo E, Gamez B, Mendez-Lucas A, et al. p38alpha function in osteoblasts influences adipose tissue homeostasis. FASEB J. 2015;29(4):1414\u201325. https:\/\/doi.org\/10.1096\/fj.14-261891.","journal-title":"FASEB J"},{"issue":"2","key":"10052_CR155","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1021\/acsnano.8b09375","volume":"13","author":"T Su","year":"2019","unstructured":"Su T, Xiao Y, Xiao Y, et al. Bone marrow mesenchymal stem cells-derived exosomal MiR-29b-3p regulates aging-associated insulin resistance. ACS Nano. 2019;13(2):2450\u201362. https:\/\/doi.org\/10.1021\/acsnano.8b09375.","journal-title":"ACS Nano"},{"key":"10052_CR156","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jot.2024.06.012","volume":"48","author":"M Yuze","year":"2024","unstructured":"Yuze M, Liu N, Shao X, et al. Mechanical loading on osteocytes regulates thermogenesis homeostasis of brown adipose tissue by influencing osteocyte-derived exosomes. J Orthop Translat. 2024;48:39\u201352. https:\/\/doi.org\/10.1016\/j.jot.2024.06.012.","journal-title":"J Orthop Translat"},{"key":"10052_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102000","volume":"88","author":"S Baroi","year":"2024","unstructured":"Baroi S, Czernik PJ, Khan MP, et al. PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation. Mol Metab. 2024;88:102000. https:\/\/doi.org\/10.1016\/j.molmet.2024.102000.","journal-title":"Mol Metab"},{"key":"10052_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1145467","volume":"14","author":"A Chougule","year":"2023","unstructured":"Chougule A, Baroi S, Czernik PJ, et al. Osteocytes contribute via nuclear receptor PPAR-alpha to maintenance of bone and systemic energy metabolism. Front Endocrinol (Lausanne). 2023;14:1145467. https:\/\/doi.org\/10.3389\/fendo.2023.1145467.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10052_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106999","volume":"26","author":"SP Kim","year":"2023","unstructured":"Kim SP, Seward AH, Garcia-Diaz J, et al. Peroxisome proliferator activated receptor-\u03b3 in osteoblasts controls bone formation and fat mass by regulating sclerostin expression. iScience. 2023;26(7):106999. https:\/\/doi.org\/10.1016\/j.isci.2023.106999.","journal-title":"iScience"},{"issue":"10","key":"10052_CR160","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.2337\/db17-0116","volume":"66","author":"J Brun","year":"2017","unstructured":"Brun J, Berthou F, Trajkovski M, et al. Bone regulates browning and energy metabolism through mature osteoblast\/osteocyte PPAR\u03b3 expression. Diabetes. 2017;66(10):2541\u201354. https:\/\/doi.org\/10.2337\/db17-0116.","journal-title":"Diabetes"},{"issue":"3","key":"10052_CR161","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11914-024-00871-5","volume":"22","author":"B Lecka-Czernik","year":"2024","unstructured":"Lecka-Czernik B, Khan MP, Letson J, et al. Regulatory effect of osteocytes on extramedullary and bone marrow adipose tissue development and function. Curr Osteoporos Rep. 2024;22(3):301\u20137. https:\/\/doi.org\/10.1007\/s11914-024-00871-5.","journal-title":"Curr Osteoporos Rep"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10052-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:12:00Z","timestamp":1779171120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10052-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":161,"alternative-id":["10052"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10052-7","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}